TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) is a Financial Services company (Asset Management) with a market capitalization of $151M. The Maz Rating grades it against the other companies in its sector.
TriplePoint Venture Growth BDC Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.70, TriplePoint Venture Growth BDC Corp. trades at 6.6x trailing earnings, 2.2x sales and 0.4x book value, with an EV/EBITDA of 13.6. Over the last twelve months it generated about $70M of revenue and $23M of net income. It runs a gross margin of 69.4%, an operating margin of 54.9% and a net margin of 30.9%. It shows return on equity of 6.2%, return on invested capital of 5.1% and a free cash flow yield of 66.2%. On the balance sheet: a debt-to-equity ratio of 1.17 and a current ratio of 4.94. Over the past 52 weeks the share price ranged from $3.68 to $6.95, with a beta of 1.43.
TriplePoint Venture Growth BDC Corp. pays a dividend yielding 26.70%, with 176% of earnings paid out. Its Maz Dividend Score is 1.17 out of 5, ranked against the other dividend payers in its sector (Safety 1.18, Growth 1.22, Yield 4.82, Consistency 1.29).
12 Wall Street analyst ratings cover the stock: 1 Buy, 10 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
TriplePoint Venture Growth BDC Corp. (TPVG) functions as a business development company, primarily concentrating its investments on growth-stage enterprises backed by venture capital. The firm's core offering involves providing debt financing solutions to companies within the venture growth ecosystem. These solutions encompass a diverse range of products, such as growth capital loans, customized and secured credit facilities, equipment financing, and revolving lines of credit. Additionally, TPVG engages in direct equity investments. Its investment strategy targets companies operating in key sectors, including e-commerce, entertainment, technology, and life sciences. Within the technology sphere, the areas of specific interest are broad, covering cybersecurity, wireless communication equipment, network systems and software, business application software, conferencing solutions, big data analytics, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, various software categories (including Software-as-a-Service), and other related technological subsectors. For life sciences, TPVG focuses on biotechnology, biofuels/biomass, diagnostic testing and bioinformatics, drug delivery systems, drug discovery, healthcare information systems, healthcare services, medical/surgical/therapeutic devices, pharmaceuticals, and other related fields. The size of TPVG's investments varies based on the type of financing: growth capital loans typically range from $5 million to $50 million, equipment financings are between $5 million and $25 million, and revolving loans generally fall between $1 million and $25 million. Direct equity investments, conversely, are usually from $0.1 million to $5 million, and are structured to not exceed 5% of the portfolio company's total equity. The debt financing instruments are commonly structured as lines of credit, and the company also employs warrants and secured loans in its funding approach. TPVG aims to achieve targeted returns of 10% to 18%. A distinctive aspect of its investment policy is that it does not seek board representation in the companies it finances.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, TriplePoint Venture Growth BDC Corp. (TPVG) is classified as NOT HALAL by Maz Vantage: its line of business (Asset Management) is excluded under every published Shariah methodology, whatever its balance sheet.
No. As of September 2026, TriplePoint Venture Growth BDC Corp. (TPVG) is classified as NOT HALAL by Maz Vantage: its line of business (Asset Management) is excluded under every published Shariah methodology, whatever its balance sheet.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.